Paper Details 
Original Abstract of the Article :
This open clinical study was designed to evaluate and compare the efficacy and side effects of lindane (1% and 0.3%), benzyl benzoate (20% and 10%) and permethrin (5% and 2.5%) after two, three, and one application at bedtime, in the treatment of scabies in 114 adults and 80 children aged between 0 ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2472724

データ提供:米国国立医学図書館(NLM)

Scabies Treatment: A Comparison of Permethrin, Lindane, and Benzyl Benzoate

The tiny [scabies mite] can cause a big problem. This study compares the effectiveness of three different treatments for scabies: [permethrin, lindane, and benzyl benzoate]. The researchers conducted an [open clinical study] involving [114 adults and 80 children], analyzing the efficacy and side effects of each treatment.

Permethrin: A Promising Solution

The study found that [permethrin] was the most effective treatment, successfully eradicating scabies in all patients. This is significant because [permethrin] is generally well-tolerated and offers a safe alternative to other treatments, particularly for [premature infants, small children, patients with seizures, and pregnant women].

The Right Treatment for the Right Terrain

Think of the desert: different areas require different strategies for survival. Similarly, choosing the best treatment for scabies requires considering the individual patient's needs and circumstances. This study provides valuable information to help guide clinicians in their treatment decisions.

Dr.Camel's Conclusion

This research suggests that permethrin is a reliable and safe treatment option for scabies. It's a promising tool for effectively addressing this common, yet often challenging, skin condition.

Date :
  1. Date Completed 1989-08-01
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

2472724

DOI: Digital Object Identifier

2472724

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.